Skip to content

E.H.D. BIO: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

E.H.D. BIO

BE 0463.253.489
NACE 86.910, Medical imaging and medical laboratories
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€216,551
2024 · €203,954+€12,597
Equity
€1.3m
2024 · €1.1m+€216,551
Cash
€463,377
2024 · €168,113+€295,264
Balance sheet total
€1.4m
2024 · €1.1m+€224,364

Largest movements

2024 to 2025
Assets
  • Cash +€295,264

    up €295,264 (+176%), from €168,113 to €463,377

    mainly Net result for the year (+€216,551) and Current investments (+€70,900)

  • Current investments -€70,900

    down €70,900 (-7.3%), from €967,534 to €896,634

Equity and liabilities
  • Reserves +€216,551

    up €216,551 (+19.8%), from €1.1m to €1.3m

Income statement
  • Gross operating margin +€31,577

    up €31,577 (+10.7%), from €296,371 to €327,948

  • Financial income -€19,677

    down €19,677 (-71.3%), from €27,603 to €7,927

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €203,954
Gross operating margin +€31,577
Staff costs -€370
Financial income -€19,677
Financial charges +€1,188
Taxes -€122
Result 2025 €216,551
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€224,369
Investment +€70,900
Financing -€5
Cash 2024 €168,113
Net result for the year +€216,551
Smaller working-capital items +€69
Tax, wage and social debts +€7,750
Current investments +€70,900
Current portion of long-term debt -€5
Cash 2025 €463,377
brings cash intakes cash out
Every line side by side 28 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,135,647 €1,360,011 +€224,364 +19.8%
Current assets 29/58 €1,135,647 €1,360,011 +€224,364 +19.8%
Current investments 50/53 €967,534 €896,634 -€70,900 -7.3%
Cash at bank and in hand 54/58 €168,113 €463,377 +€295,264 +176%
Total equity and liabilities 10/49 €1,135,647 €1,360,011 +€224,364 +19.8%
Equity 10/15 €1,093,619 €1,310,170 +€216,551 +19.8%
Reserves 13 €1,093,619 €1,310,170 +€216,551 +19.8%
Distributable reserves 133 €1,093,619 €1,310,170 +€216,551 +19.8%
Amounts payable 17/49 €42,028 €49,842 +€7,814 +18.6%
Amounts payable within one year 42/48 €42,028 €49,842 +€7,814 +18.6%
Current portion of amounts payable after more than one year 42 €5,987 €5,982 -€5 -0.1%
Trade debts 44 €945 €1,275 +€330 +34.9%
Suppliers 440/4 €945 €1,275 +€330 +34.9%
Taxes, remuneration and social security 45 €23,260 €31,010 +€7,750 +33.3%
Taxes 450/3 €21,748 €29,450 +€7,702 +35.4%
Remuneration and social security 454/9 €1,512 €1,560 +€48 +3.2%
Other amounts payable 47/48 €11,837 €11,575 -€261 -2.2%
Remuneration, social security and pensions 62 €12,029 €12,399 +€370 +3.1%
Gross operating margin 9900 €296,371 €327,948 +€31,577 +10.7%
Operating profit (loss) 9901 €284,341 €315,549 +€31,208 +11.0%
Financial income 75/76B €27,603 €7,927 -€19,677 -71.3%
Recurring financial income 75 €27,603 €7,927 -€19,677 -71.3%
Financial charges 65/66B €6,290 €5,101 -€1,188 -18.9%
Recurring financial charges 65 €6,290 €5,101 -€1,188 -18.9%
Profit (loss) for the period before taxes 9903 €305,655 €318,374 +€12,719 +4.2%
Income taxes 67/77 €101,701 €101,823 +€122 +0.1%
Profit (loss) for the period 9904 €203,954 €216,551 +€12,597 +6.2%
Profit (loss) for the period to be appropriated 9905 €203,954 €216,551 +€12,597 +6.2%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.